| # | Drug | Count |
|---|---|---|
| 0 | HUMAN IMMUNOGLOBULIN G | 383 |
| 1 | RITUXIMAB | 325 |
| 2 | OCRELIZUMAB | 289 |
| 3 | PREDNISONE | 257 |
| 4 | ACETAMINOPHEN | 233 |
| 5 | ACETAMINOPHEN 500MG | 176 |
| 6 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 176 |
| 7 | PAIN RELIEVER | 176 |
| 8 | METHYLPREDNISOLONE | 175 |
| 9 | DIPHENHYDRAMINE HYDROCHLORIDE | 158 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN IMMUNOGLOBULIN G | 383 | 0.0183 |
| 1 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 7 | 0.0144 |
| 2 | ZANUBRUTINIB | 49 | 0.0108 |
| 3 | IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE | 38 | 0.0093 |
| 4 | SATRALIZUMAB | 11 | 0.0061 |
| 5 | ELRANATAMAB-BCMM | 7 | 0.0060 |
| 6 | EPCORITAMAB-BYSP | 8 | 0.0060 |
| 7 | AXICABTAGENE CILOLEUCEL | 60 | 0.0059 |
| 8 | IMMUNE GLOBULIN SUBCUTANEOUS (HUMAN) | 26 | 0.0056 |
| 9 | EFGARTIGIMOD ALFA | 20 | 0.0050 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 727 |
| 1 | Corticosteroid [EPC] | 615 |
| 2 | Human Immunoglobulin G [EPC] | 444 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 323 |
| 4 | Kinase Inhibitor [EPC] | 196 |
| 5 | Alkylating Drug [EPC] | 159 |
| 6 | Provitamin D2 Compound [EPC] | 142 |
| 7 | Benzodiazepine [EPC] | 130 |
| 8 | Proton Pump Inhibitor [EPC] | 128 |
| 9 | Thalidomide Analog [EPC] | 115 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 16 | 0.0233 |
| 1 | Human Immunoglobulin G [EPC] | 444 | 0.0211 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 69 | 0.0118 |
| 3 | Neonatal Fc Receptor Blocker [EPC] | 36 | 0.0082 |
| 4 | CD19-directed Cytolytic Antibody [EPC] | 7 | 0.0082 |
| 5 | Endoglycosidase [EPC] | 13 | 0.0070 |
| 6 | CD19-directed Chimeric Antigen Receptor [EPC] | 60 | 0.0059 |
| 7 | Provitamin D2 Compound [EPC] | 142 | 0.0048 |
| 8 | Interferon gamma Blocker [EPC] | 1 | 0.0042 |
| 9 | Adrenocorticotropic Hormone [EPC] | 3 | 0.0034 |